Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Clinical Trials, High Risk Prostate Cancer, Non-Metastatic Castration Resistant Prostate Cancer (nMCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06451497
Phase: PHASE1
Trial Summary: This is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Pembrolizumab in patients with advanced solid tumors who have exhausted all stand – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Zumutor Biologics Inc.
Acronym:

Pin It on Pinterest